ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2360

Glucocorticoids and Vascular Function in Arthritis: Benefic or Deleterious Effects? Study in Rat

Frank Verhoeven1, Katy Maguin-Gaté2, Perle Totoson3, Daniel Wendling4 and Céline Demougeot5, 1Rheumatology, CHU jean Minjoz, Besançon, France, 2EA 4267 « Fonctions et Dysfonctions Epithéliales » , Faculté de Médecine-Pharmacie, Besançon, France, 3UFR Sciences Médicales et Pharmaceutiques, EA 4267 "Fonctions et Dysfonctions Epithéliales", besançon, France, 4Service de Rhumatologie, CHU J Minjoz, Besancon, France, 5UFR Sciences Médicales et Pharmaceutiques, EA 4267 "Fonctions et Dysfonctions Epithéliales", Besançon, France

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: adjuvant arthritis, Cardiovascular disease, endothelial cells and glucocorticoids

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Animal Models

Session Type: Abstract Submissions (ACR)

Background/Purpose: Rheumatoid Arthritis (RA) is associated to an increase of cardiovascular (CV) risk explained in part by an accelerated atherosclerosis as a consequence of endothelial dysfunction. Glucocorticoids (GCs) are widely prescribed in RA patients. Surprisingly, despite the commonly held belief that glucocorticoids worsen the CV risk, data concerning their impact on endothelial function in RA are lacking. The present study investigate the effect of prednisolone on vascular function in arthritic rats and identified the underlying mechanisms.

Methods : Adjuvant-induced arthritis (AIA) was induced in 6 weeks old male Lewis rats by injection of Mycobacterium butyricum in adjuvant at the basis of the tail. At the onset of arthritis, rats were daily treated (i.p) with prednisolone at 10 (high dose) or 0.1 mg / kg (Low dose) or saline (Vehicle) for 21 days. Arthritis score and tarsus diameter were daily monitored. At the end of treatment, thoracic aortas were harvested to measure the relaxation to acetylcholine on pre-constricted aortic rings in the presence or not of inhibitor of nitric oxide (NO) synthase (L-NAME), arginase (nor-NOHA), COX-2 (NS-398), EDHF (Apamin/Charybdotoxin), or a superoxide dismutase analog (Tempol). The relaxing effect of a NO donor (sodium nitroprussiate, SNP) was studied on endothelium-denuded aortic rings. Blood pressure and heart rate, glycaemia, triglyceride and total cholesterol levels and radiological score of hind paws were also assessed.

Results: Compared to “Vehicle”, AIA “High dose” exhibited reduced (p<0.05) arthritic score, paw diameters and radiological damage. This dose of GC significantly (p<0.05) improved Ach-induced relaxation through increased NO synthase activity and EDHF production, decreased arginase and COX-2 activities and decreased superoxide anions production. Blood pressure and triglyceride level were significantly (p<0.05) higher in AIA “high dose”. By contrast, the low dose of prednisolone modified nor arthritis severity neither blood pressure, glycaemia and triglycerides levels. On the vascular side, this dose decreased the production of superoxide anions and increased EDHF, but failed to improve endothelial function in AIA rats. The response of rings to the NO donor was unchanged after GC treatment whatever the dose.

Conclusion: Our study demonstrates for the first time that a high dose of prednisolone during a short time is beneficial for endothelial function in case of arthritis, even though it induced deleterious cardio-metabolic effects. From a clinical perspective, these results raise the question of the use of high doses of GC during a short period to reverse endothelial dysfunction along with a rapid disease control. Whether this beneficial vascular effect of GC depends on the reduction of disease activity or not deserves further investigations.


Disclosure:

F. Verhoeven,
None;

K. Maguin-Gaté,
None;

P. Totoson,
None;

D. Wendling,
None;

C. Demougeot,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/glucocorticoids-and-vascular-function-in-arthritis-benefic-or-deleterious-effects-study-in-rat/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology